We supported the grant application that Professor James Chalmers was awarded for the STOP-COVID19
clinical trial, funded by the pharmaceutical company INSMED. The usual
time frame for setting up a clinical trial is six months-plus. Our team
have worked extremely hard to set up this clinical trial in a third of
that time.
The STOP-COVID19 trial is the first Scottish-led coronavirus trial
and is taking place across 16 hospitals in the UK. It investigates
whether a new anti-inflammatory drug, Brensocatib, can reduce the length
of hospital stay and the number of patients who require mechanical
ventilation. The first patient for this trial was recruited in Tayside
at the start of June.